A Retrospective Analysis of the Presentation, Outcomes and Determinants of Severity of Postoperative Pneumonia in Upper Abdominal Oncological Surgeries
Prasanna V Vanamail, Radhika Dash, Kalpana Balakrishnan
Citation Information :
Vanamail PV, Dash R, Balakrishnan K. A Retrospective Analysis of the Presentation, Outcomes and Determinants of Severity of Postoperative Pneumonia in Upper Abdominal Oncological Surgeries. Indian J Respir Care 2020; 9 (1):52-57.
Context: Postoperative pneumonia (POP) is a major cause of morbidity following upper abdominal oncological surgeries.
Aims: To estimate the incidence of POP following upper abdominal oncological surgeries and to identify its clinical and microbiologic features and the risk factors for the development of severe pneumonia.
Settings and Design: Retrospective analysis of patients with POP at a regional cancer center.
Patients and Methods: Patients’ preoperative and intraoperative details and data on clinical and radiological features and pathogens isolated were collected. Patients with severe pneumonia were identified on the basis of Infectious Disease Society of America/American Thoracic Society criteria and their predictors were estimated. The types of respiratory support required and their outcomes were analysed.
Statistical Analysis Used: Parametric Student's t-independent test was used to compare two groups’ means. Categorical data are presented as frequency and percentage values. P < 0.05 was considered statistically significant.
Results: Incidence of POP was 15.24% with 48% developing severe pneumonia. There was a significant difference in the mean age (59.5 ± 8.62 vs. 50.15 ± 10.53 years, P = 0.024), duration of surgery (315.77 ± 107.29 vs. 432.92 ± 177.18 min, P = 0.055), blood loss (446.15 ± 260.18 ml vs. 712.5 ± 326.22 ml), time to empiric antibiotic (15.69 ± 5.77 vs. 42 ± 38.12 h, P = 0.022), and symptom resolution =3 days (23.1% vs. 72.7%) between patients with nonsevere and severe pneumonia. Patients presenting with cough (odds ratio = 0.06, 95% confidence interval: 0.006–0.618) were more likely to have nonsevere pneumonia.
Conclusions: Predictors of severe pneumonia are elderly, prolonged surgical duration, higher blood loss, delayed empiric antibiotic and delayed symptom resolution.
Kinugasa S, Tachibana M, Yoshimura H, Ueda S, Fujii T, Dhar DK, et al. Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy. J Surg Oncol 2004;88:71-7.
Smetana GW, Pfeifer KJ, Slawski BA, Jaffer AK, Dutta S, Cohn SL. Risk factors for postoperative pulmonary complications: An update of the literature. Hosp Pract (1995) 2014;42:126-31.
McAlister FA, Bertsch K, Man J, Bradley J, Jacka M. Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med 2005;171:514-7.
Inokuchi M, Kojima K, Kato K, Sugita H, Sugihara K. Risk factors for post-operative pulmonary complications after gastrectomy for gastric cancer. Surg Infect (Larchmt) 2014;15:314-21.
Shirinzadeh A, Talebi Y. Pulmonary complications due to esophagectomy. J Cardiovasc Thorac Res 2011;3:93-6.
Kodra N, Shpata V, Ohri I. Risk factors for postoperative pulmonary complications after abdominal surgery. Open Access Maced J Med Sci 2016;4:259-63.
Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr, et al. Hospital costs associated with surgical complications: A report from the private-sector national surgical quality improvement program. J Am Coll Surg 2004;199:531-7.
Jin LX, Sanford DE, Squires MH 3rd, Moses LE, Yan Y, Poultsides GA, et al. Interaction of postoperative morbidity and receipt of adjuvant therapy on long-term survival after resection for gastric adenocarcinoma: Results from the U.S. Gastric cancer collaborative. Ann Surg Oncol 2016;23:2398-408.
Tu RH, Lin JX, Li P, Xie JW, Wang JB, Lu J, et al. Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer. Cancer Med 2017;6:2757-65.
Trinh VQ, Ravi P, Abd-El-Barr AE, Jhaveri JK, Gervais MK, Meyer CP, et al. Pneumonia after major cancer surgery: Temporal trends and patterns of care. Can Respir J 2016;2016:6019416. doi:10.1155/2016/6019416.
Abbott TEF, Fowler AJ, Pelosi P, Gama de Abreu M, Møller AM, Canet J, et al. A systematic review and consensus definitions for standardised end-points in perioperative medicine: Pulmonary complications. Br J Anaesth 2018;120:1066-79.
Brown SM, Jones BE, Jephson AR, Dean NC, Infectious Disease Society of America/American Thoracic Society 2007. Validation of the infectious disease society of america/American thoracic society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med 2009;37:3010-6.
Khilnani GC, Zirpe K, Hadda V, Mehta Y, Madan K, Kulkarni A, et al. Guidelines for antibiotic prescription in intensive care unit. Indian J Crit Care Med 2019;23:S1-63.
Phua J, See KC, Chan YH, Widjaja LS, Aung NW, Ngerng WJ, et al. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 2009;64:598-603.
Stéphan F, Zarrouki Y, Mougeot C, Imbert A, Kortchinsky T, Pilorge C, et al. Non-ventilator ICU-acquired pneumonia after cardiothoracic surgery: Accuracy of diagnostic tools and outcomes. Respir Care 2016;61:324-32.
Dubourg G, Abat C, Rolain JM, Raoult D. Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol 2015;53:994-6.
Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British thoracic society guideline for diagnostic flexible bronchoscopy in adults: Accredited by NICE. Thorax 2013;68 Suppl 1:i1-44.
Fujita T, Ishida Y, Yanaga K. Impact of appropriateness of initial antibiotic therapy on outcome of postoperative pneumonia. Langenbecks Arch Surg 2008;393:487-91.
Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, Tateda K, et al. Alveolar macrophage deactivation in murine septic peritonitis: Role of interleukin 10. Infect Immun 2001;69:1394-401.
Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112-24.
Angele MK, Chaudry IH. Surgical trauma and immunosuppression: Pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 2005;390:333-41.
Kim WY, Sung H, Hong SB, Lim CM, Koh Y, Lyu J, et al. Outcome of high-flow nasal cannula for acute hypoxemic respiratory failure due to pneumocystis pneumonia. In: 2.2 Noninvasive Ventilatory Support. Vol 48. London, UK: European Respiratory Society; 2016. p. 3052.
Sztrymf B, Messika J, Bertrand F, Hurel D, Leon R, Dreyfuss D, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: A prospective pilot study. Intensive Care Med 2011;37:1780-6.
Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185-96.
Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 2015;41:623-32.
Khan RA, Bakry MM, Islahudin F. Appropriate antibiotic administration in critically ill patients with pneumonia. Indian J Pharm Sci 2015;77:299-305.
Cué JI, Peyton JC, Malangoni MA. Does blood transfusion or hemorrhagic shock induce immunosuppression? J Trauma 1992;32:613-7.
Mizuno A, Kanda M, Kobayashi D, Tanaka C, Iwata N, Yamada S, et al. Adverse effects of intraoperative blood loss on long-term outcomes after curative gastrectomy of patients with stage II/III gastric cancer. Dig Surg 2016;33:121-8.
Adeniji K, Steel AC. The pathophysiology of perioperative lung injury. Anesthesiol Clin 2012;30:573-90.
Han S, Mallampalli RK. The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc 2015;12:765-74.